Skip to main content
. 2016 Sep 14;7(45):72819–72832. doi: 10.18632/oncotarget.12022

Table 1. Results of CD68 and CD20 immunohistochemistry scoring.

Immune marker CD68 n (%) CD20 n (%)
Dichotomized total score* < 8 vs ≥ 8 < 5 vs ≥ 5
 Low expression 65 (46.1) 50 (35.5)
 High expression 76 (53.9) 91 (64.5)
Dichotomized tumor (intraepithelial) compartment score < 2 vs ≥ 2 < 2 vs ≥ 2
 Low expression 33 (23.4) 118 (83.6)
 High expression 108 (76.6) 23 (16.4)
Dichotomized stroma compartment score < 3 vs ≥ 3 < 2 vs ≥ 2
 Low expression 30 (21.3) 46 (32.6)
 High expression 111 (78.7) 95 (67.4)
Dichotomized peripheral compartment score < 3 vs ≥ 3 < 2 vs ≥ 2
 Low expression 52 (36.9) 12 (8.5)
 High expression 89 (63.1) 129 (91.5)
*

Dichotomized labelling (low vs high expression) based on the median value of immune marker expression. Total score accounted for all three compartment scores (tumor, stroma, periphery).